{"id":"W2569560965","doi":"10.5489/cuaj.4307","title":"First-line treatment options in metastatic renal cell cancer","year":2016,"lang":"en","type":"review","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"ca_institutions":"Canadian Urological Association","funders":"","keywords":"Temsirolimus; Pazopanib; Sunitinib; Renal cell carcinoma; Medicine; Oncology; Discovery and development of mTOR inhibitors; Targeted therapy; Internal medicine; PI3K/AKT/mTOR pathway; Angiogenesis; Cancer research; Vascular endothelial growth factor; Cancer; VEGF receptors; Biology; Signal transduction","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":true,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003352162,0.0005404027,0.001037893,0.001578753,0.0002435619,0.0006989351,0.0007414066,0.0007740142,0.00698298],"category_scores_gemma":[0.0006864694,0.0001462284,0.0006957103,0.0009705913,0.0002361698,0.0008438669,0.0004521529,0.001427683,0.00178931],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004768435,"about_ca_system_score_gemma":0.0006903892,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001194042,"about_ca_topic_score_gemma":0.003995125,"domain_scores_codex":[0.9998373,0.00003382565,0.00002588822,0.00002319813,0.00006483821,0.00001501544],"domain_scores_gemma":[0.999792,0.00009821592,0.00004496592,0.000005421922,0.00004151852,0.00001793219],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0000640023,0.00006049627,0.0001974382,0.02414829,0.0001308201,0.0002802686,0.0000521784,0.0002964247,0.000699676,0.002153133,0.03829718,0.9336202],"study_design_scores_gemma":[0.00003582449,0.00009548898,0.0009749057,0.01363889,0.0002102434,0.00291565,0.00006392488,0.00009378461,0.0003673898,0.001889213,0.9796979,0.00001664663],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001002737,0.9985365,0.00005423555,0.0002199326,0.00009756033,0.000003396744,0.00002121945,0.00000399844,0.000962863],"genre_scores_gemma":[0.001381064,0.9975201,0.0001275958,0.000267567,0.0001369423,0.000005469804,0.00005913673,0.000001286991,0.0005007804],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.00698298,"threshold_uncertainty_score":0.02336043,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0673418987590646,"score_gpt":0.3166088914079583,"score_spread":0.2492669926488937,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}